ARDF Strategy
Fund
The ARDF
Annual Open Grant Program was established to fund research projects that develop alternative methods or utilize an alternative approach in research, testing or education. Over $4 million in grants have been awarded to date.
ARDF's new
Alternatives in Research (AiR) Challenge program will stimulate innovation in alternative methods, focused on biomedical research.
Promote
ARDF works to promote alternatives through the sponsorship of scientific meetings across the globe, participation in regulatory and industry meetings, and providing free consultations with media representatives, scientists, and government officials. ARDF also engages in legal advocacy to accelerate acceptance and utilization of alternative methods, such as its successful legal petitions to National Institutes of Health to require its grantees to produce monoclonal antibodies via
in vitro methods, as opposed to traditional mouse ascites.
Reward
Recognizing individuals in the scientific community who have made extraordinary contributions to the advancement of alternatives, ARDF rewards scientists through its
William and Eleanor Cave Award.
Leadership
Sue A. Leary | President
Sue A. Leary has been President and CEO of ARDF since 1995. She has a B.S. in Biology and M.S. in Nonprofit Management. Her career has focused on coordination of programs and services; education and advocacy; administration and planning; and membership development in nonprofit organizations. Since 1995, she has served as President of the Alternatives Research & Development Foundation (ARDF) and its affiliate, American Anti-Vivisection Society (AAVS). Ms. Leary is Executive Editor of the AV Magazine, and Chair of the Coalition for Consumer Information on Cosmetics (CCIC), which operates the Leaping Bunny Program. She has served on a number of boards, including the Global Federation of Animal Sanctuaries.
Martin L. Stephens | Scientific Consultant
Martin L. Stephens is a senior research associate at the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and a scientific consultant to the Alternatives Research & Development Foundation (ARDF). In both positions, he promotes animal-friendly methods in research, testing, and education. At CAAT, he is deputy director of the Evidence-based Toxicology Collaboration, where he develops new approaches to assessing the performance of test methods. Prior to joining Johns Hopkins University in 2011, Dr. Stephens was vice president for animal research issues at The Humane Society of the United States. He served on the National Academy of Sciences' committee that produced the landmark report on Toxicity Testing in the 21st Century: A Vision and a Strategy. Dr. Stephens has received numerous awards for his contributions to alternative methods and animal protection, including the Society of Toxicology's Enhancement of Animal Welfare Award. He received a Ph.D. in biology from The University of Chicago.
Board of Directors
Sue A. Leary |
President
Joseph Ludwig |
Vice President
Aaron McIntyre |
Treasurer
Denise Cowie |
Secretary
Douglas R. Barr, Sr.
Robert Finn
Frank Krafchik
